Cargando…

Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB(0,+), LAT1 and LAT2

The efficacy of boron neutron capture therapy relies on the selective delivery of boron carriers to malignant cells. p-Boronophenylalanine (BPA), a boron delivery agent, has been proposed to be localized to cells through transporter-mediated mechanisms. In this study, we screened aromatic amino acid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wongthai, Printip, Hagiwara, Kohei, Miyoshi, Yurika, Wiriyasermkul, Pattama, Wei, Ling, Ohgaki, Ryuichi, Kato, Itsuro, Hamase, Kenji, Nagamori, Shushi, Kanai, Yoshikatsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376436/ https://www.ncbi.nlm.nih.gov/pubmed/25580517 http://dx.doi.org/10.1111/cas.12602

Ejemplares similares

Establishment of Stable Cell Lines With High Expression of Heterodimers of Human 4F2hc and Human Amino Acid Transporter LAT1 or LAT2 and Delineation of Their Differential Interaction With α-Alkyl Moieties
por: Khunweeraphong, Narakorn, et al.
Publicado: (2012)

Specific transport of 3‐fluoro‐l‐α‐methyl‐tyrosine by LAT1 explains its specificity to malignant tumors in imaging
por: Wei, Ling, et al.
Publicado: (2016)

Inhibition of cancer-type amino acid transporter LAT1 suppresses B16-F10 melanoma metastasis in mouse models
por: Shi, Zitong, et al.
Publicado: (2023)

Amino acid transporter LAT1 in tumor-associated vascular endothelium promotes angiogenesis by regulating cell proliferation and VEGF-A-dependent mTORC1 activation
por: Quan, Lili, et al.
Publicado: (2020)

Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine.
por: Morris, G. M., et al.
Publicado: (1997)

Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor
por: Okanishi, Hiroki, et al.
Publicado: (2020)

Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy with Boronophenylalanine
por: Kondo, Natsuko, et al.
Publicado: (2020)

Correlation between the expression of LAT1 in cancer cells and the potential efficacy of boron neutron capture therapy
por: Watanabe, Tsubasa, et al.
Publicado: (2022)

Simple But Efficacious Enrichment of Integral Membrane Proteins and Their Interactions for In-Depth Membrane Proteomics
por: Kongpracha, Pornparn, et al.
Publicado: (2022)

Pharmacologic inhibition of LAT1 predominantly suppresses transport of large neutral amino acids and downregulates global translation in cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2022)

Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma
por: Isoda, Atsushi, et al.
Publicado: (2014)

Combination effects of amino acid transporter LAT1 inhibitor nanvuranlat and cytotoxic anticancer drug gemcitabine on pancreatic and biliary tract cancer cells
por: Nishikubo, Kou, et al.
Publicado: (2023)

The Therapeutic Effects of Dodecaborate Containing Boronophenylalanine for Boron Neutron Capture Therapy in a Rat Brain Tumor Model
por: Fukuo, Yusuke, et al.
Publicado: (2020)

Membrane transport proteins in melanosomes: Regulation of ions for pigmentation
por: Wiriyasermkul, Pattama, et al.
Publicado: (2020)

NI-04 Evaluation of post boron neutron capture therapy for recurrent meningioma using fluoride-labeled boronophenylalanine PET
por: Takai, Satoshi, et al.
Publicado: (2020)

Evaluation of the Key Advantages between Two Modalities of Boronophenylalanine Administration for Clinical Boron Neutron Capture Therapy Using an Animal Model
por: Lin, Yu-Chuan, et al.
Publicado: (2022)

5-Aminolevulinic acid increases boronophenylalanine uptake into glioma stem cells and may sensitize malignant glioma to boron neutron capture therapy
por: Fukumura, Masao, et al.
Publicado: (2023)

Biodistribution of Boron Concentration on Melanoma‐bearing Hamsters after Administration of p‐, m‐, o‐Boronophenylalanine
por: Hiratsuka, Junichi, et al.
Publicado: (2000)

LAT1 expression influences Paneth cell number and tumor development in Apc(Min/+) mice
por: Sui, Yunlong, et al.
Publicado: (2023)

Correction: LAT1 expression influences Paneth cell number and tumor development in Apc(Min/+) mice
por: Sui, Yunlong, et al.
Publicado: (2023)

Ratiometric fluorescence imaging of cell surface pH by poly(ethylene glycol)-phospholipid conjugated with fluorescein isothiocyanate
por: Ohgaki, Ryuichi, et al.
Publicado: (2017)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Boron Neutron Capture Therapy (BNCT) for Cutaneous Malignant Melanoma Using (10)B-p-Boronophenylalanine (BPA) with Special Reference to the Radiobiological Basis and Clinical Results
por: Fukuda, Hiroshi
Publicado: (2021)

Analyzing spatial distribution between (18)F-fluorodeoxyglucose and (18)F-boronophenylalanine positron emission tomography to investigate selection indicators for boron neutron capture therapy
por: Nakaichi, Tetsu, et al.
Publicado: (2022)

Evaluation of LATS1 and LATS2 Promoter Methylation with the Risk of Pterygium Formation
por: Najafi, Maryam, et al.
Publicado: (2016)

Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT
por: Lo, Wan-Lin, et al.
Publicado: (2018)

LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function
por: Tang, Fengyuan, et al.
Publicado: (2019)

Hiphop-låt förklarar domedagsmaskinen
Publicado: (2008)

GLAST LAT full simulation
por: Baldini, L
Publicado: (2006)

Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer
por: Ma, Li-cong, et al.
Publicado: (2020)

Boron-peptide conjugates with angiopep-2 for boron neutron capture therapy
por: Xiang, Jing, et al.
Publicado: (2023)

α‐Emitting cancer therapy using (211)At‐AAMT targeting LAT1
por: Kaneda‐Nakashima, Kazuko, et al.
Publicado: (2021)

LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic state
por: Furth, Noa, et al.
Publicado: (2018)

Ca(2+)-mediated higher-order assembly of heterodimers in amino acid transport system b(0,+) biogenesis and cystinuria
por: Lee, Yongchan, et al.
Publicado: (2022)

Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy
por: Morris, G M, et al.
Publicado: (2000)

Nanostructured Boron Nitride With High Water Dispersibility For Boron Neutron Capture Therapy
por: Singh, Bikramjeet, et al.
Publicado: (2016)

Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers
por: Oloo, Sebastian O., et al.
Publicado: (2023)

Latest Results from Fermi-LAT
por: Prof. MICHELSON, Peter
Publicado: (2015)

MSSM in view of PAMELA and Fermi-LAT
por: Bajc, Borut, et al.
Publicado: (2010)

Phylogeny and taxonomy of the genus Tubakia s. lat.
por: Braun, U., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kmgmkbc1jkquqte1bpmrn58297